- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06172608
Effect of Educational Program on Parental Stress of Parents of Children With CHD
Effect of Educational Program on Parental Stress of Parents of Children With Congenital Heart Disease Undergoing Cardiac Surgery: Quasi Experimental Study
Congenital Heart disease accounts for about one third of the all congenital anomalies. In last decades' huge advancements occurred in treatment and diagnosis. More and more surgeries are being done which causes stress in parents and affects their mental health. Some studies have reported that about one third of the parents of children with CHD remain in stress even after surgery is being done. The goal of this trial is to evaluate effect of educational intervention on mental health of parents of children with congenital heart disease undergoing cardiac surgery compared to the parents who get usual care and pamphlets of the same information.
The investigators are including parents of children with CHD who are already diagnosed with CHD and are undergoing cardiac surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: HAMAYUN KHAN
- Phone Number: 16638144502
- Email: hamayunkhn1@gmail.com
Study Locations
-
-
Henan
-
Zhengzhou, Henan, China, 450000
- Zhengzhou University,
-
Contact:
- Zhang Wei Hong, PhD
- Phone Number: 18638127788
- Email: zwhong306@zzu.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Parents of children with congenital heart disease
- Patient is scheduled for elective cardiac surgery and not had any surgery before.
- Willing to participate in the study
Exclusion Criteria:
- Parents of CHD who have other critical conditions along with CHD
- Parents able to understand local languages (Urdu and Pashto)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group (I)
Intervention group (I) will be receiving a psychoeducational intervention along with routine care they are getting in the hospital
|
. Intervention group (I) will receive psychosocial education which will be consist of two parts. 1) Face to Face 2) Community based intervention.
|
No Intervention: Control group (C)
Comparison usual care and Leaflet of the information.
At the end of the trial these also get the video and educational sessions as intervention group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Parental stress in parents of children with congenital Heart disease
Time Frame: [Time Frame: INTERVENTION group (I) Baseline (beginning of the study); at 1 day of discharge time and 12 weeks after discharge from hospital].
|
Stress changes will be measured via Parental Stress Scale (PSS).
The PSS is scored by summing the scores for all 18 items.
The total score can range from 18 to 90, with higher scores indicating higher levels of parental stress.
The PSS also has two subscales: Child Demandingness (CD) and Parental Competence (PC).
PSS scores are interpreted based on the following ranges: 18-37 low stress, 38-56 Moderate stress and 57-90 as high stress.
|
[Time Frame: INTERVENTION group (I) Baseline (beginning of the study); at 1 day of discharge time and 12 weeks after discharge from hospital].
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes on parental QoL
Time Frame: [ Time Frame: INTERVENTION group - Baseline (beginning of the study); at 1 day of time of discharge and 12 weeks after intervention. CONTROL group - baseline; at time of discharge and 12 weeks after intervention.]
|
Changes on parental quality of life will be assessed through World Health Organization Quality of Life-Bref (WHOQOL-Bref).
The WHOQOL-Bref instrument is composed by 26 items, which are organized in 4 specific domains: Physical (7 items), Psychological (6 items), Social Relationships (3 items), Environment (8 items) and a general QoL facet (2 items).
All items are quoted from 1 to 5. Three items, related to questions posed negatively (Q3, Q4 and Q26), must be reversed (the calculation implies the subtraction of their value to six units).
The results are transformed on a scale of 0 to 100.
Each domain score is computed through the formula: [(sum of all items - number of items) / (4x number of items)] x 100.
Higher scores correspond to better quality of life.
|
[ Time Frame: INTERVENTION group - Baseline (beginning of the study); at 1 day of time of discharge and 12 weeks after intervention. CONTROL group - baseline; at time of discharge and 12 weeks after intervention.]
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression in parents of children with CHD
Time Frame: [Time Frame: INTERVENTION group (I) Baseline (beginning of the study); at 1 day of discharge time and 12 weeks after discharge from hospital]
|
Depression in parents of children with CHD will be assessed through DASS.
The Depression Anxiety Stress Scales (DASS) is a self-report questionnaire that assesses the three most common negative emotional states: depression, anxiety, and stress.
It is a widely used tool in research and clinical settings to measure these symptoms and their impact on an individual's well-being.
Each item on the DASS is rated on a 4-point Likert scale, ranging from 0 (never) to 3 (almost always).
The total score for each subscale is calculated by summing the scores for the items on that subscale.
Higher scores on each subscale indicate more severe symptoms.
|
[Time Frame: INTERVENTION group (I) Baseline (beginning of the study); at 1 day of discharge time and 12 weeks after discharge from hospital]
|
Anxiety in parents of children with CHD
Time Frame: [Time Frame: INTERVENTION group (I) Baseline (beginning of the study); at 1 day of discharge time and 12 weeks after discharge from hospital]
|
Anxiety in parents of children with CHD will be assessed through DASS.
The Depression Anxiety Stress Scales (DASS) is a self-report questionnaire that assesses the three most common negative emotional states: depression, anxiety, and stress.
It is a widely used tool in research and clinical settings to measure these symptoms and their impact on an individual's well-being.
Each item on the DASS is rated on a 4-point Likert scale, ranging from 0 (never) to 3 (almost always).
The total score for each subscale is calculated by summing the scores for the items on that subscale.
Higher scores on each subscale indicate more severe symptoms.
|
[Time Frame: INTERVENTION group (I) Baseline (beginning of the study); at 1 day of discharge time and 12 weeks after discharge from hospital]
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-296
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Defect
-
Occlutech International ABRecruitingMuscular Ventricular Septal DefectTurkey
-
Asklepion Pharmaceuticals, LLCCompletedAtrial Septal Defect | Atrioventricular Septal Defect | Ventricular Septal DefectUnited States
-
Ayman khairy MohamedCompletedAtrial Septal Defect, Secundum TypeEgypt
-
Abbott Medical DevicesTerminatedAtrial Septal Defect SecundumUnited States
-
GLYCAR SA (Pty) LtdRecruitingCardiac Anomaly | Cardiac Defect | Pericardial DefectSouth Africa
-
Assiut UniversityWithdrawnASD2(Secundum Atrial Septal Defect)
-
Chinese Academy of Medical Sciences, Fuwai HospitalUnknownPerimembranous Ventricular Septal DefectChina
-
Occlutech International ABActive, not recruitingPerimembranous Ventricular Septal DefectThailand, Germany, Ireland, Vietnam
-
Lund University HospitalGöteborg University; Region Jönköping CountyActive, not recruitingCardiovascular Diseases | Atrial Septal Defect | Patent Ductus Arteriosus | Ventricular Septal Defect | Aortopulmonary Window | Heart Disease Congenital | Partial Anomalous Pulmonary Venous ConnectionSweden
-
Nobles Medical Technologies II IncEnrolling by invitationForamen Ovale, Patent | Septal Defect, Atrial | Septal Defect, HeartUnited States, Italy
Clinical Trials on psychoeducational intervention
-
Universidad de MonterreyFEMSA Foundation; Mexican Food BanksCompletedMalnutrition | Malnutrition, Child | Malnutrition in Children | Child Malnutrition | Child Overnutrition | Nutrition Disorders, ChildMexico
-
Emory UniversityNational Institute on Aging (NIA)Completed
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)Completed
-
M.D. Anderson Cancer CenterRecruitingFatigue | Metastatic CancersUnited States
-
Copenhagen University Hospital, HvidovreRecruitingCOVID-19 | Anxiety | Mental Health | PsychoeducationDenmark
-
Rosa JimenezTerminatedSexually Transmitted Diseases, Viral | Sexually Transmitted Diseases | Sexually Transmitted Diseases, BacterialChile
-
University of British ColumbiaCompletedSexual Dysfunctions, PsychologicalCanada
-
University of New MexicoHyundai Hope On WheelsWithdrawn
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Centro de Investigação em Tecnologias... and other collaboratorsCompletedCongenital Heart DefectsPortugal
-
Consorci Hospitalari de VicGovernment of CataloniaCompleted